IDH1 and neoplasm: For instance, specific NAB2-STAT6 mutations have been shown to possess prognostic value regarding the potential for metastasis formation.23 Additionally, risk stratification models based on molecular markers, such as IDH1 mutations or PD-L1 expression, might predict tumor progression.24